ChemicalBook >> CAS DataBase List >>Galeterone

Galeterone

CAS No.
851983-85-2
Chemical Name:
Galeterone
Synonyms
VN 124;CS-232;NX41765;TOK-001;VN/124-1;Galeterone;Galaterone;synthesis-008;synthesis-1-007;TOK-001 impurity
CBNumber:
CB32500945
Molecular Formula:
C26H32N2O
Molecular Weight:
388.55
MDL Number:
MFCD16660907
MOL File:
851983-85-2.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-05-28 01:05:11
Product description Number Pack Size Price
Galeterone ≥98% (HPLC) SML1375 5MG $86
Galeterone ≥98% (HPLC) SML1375 25MG $331
Galeterone ≥98% 17586 1mg $28
Galeterone ≥98% 17586 5mg $97
Galeterone ≥98% 17586 10mg $152
More product size

Galeterone Properties

Melting point 189-190℃
Boiling point 564.5±60.0 °C(Predicted)
Density 1.28
storage temp. -20°C Freezer
solubility Chloroform (Slightly), Ethyl Aceatae (Slightly, Heated)
pka 14.71±0.70(Predicted)
form Solid
color White to Off-White
InChIKey PAFKTGFSEFKSQG-MRFMOSGMNA-N
SMILES C1C[C@]2(C)C3CC[C@]4(C)C([n]5cnc6ccccc56)=CCC4C3CC=C2C[C@H]1O |&1:2,7,27,r|
FDA UNII WA33E149SW
NCI Drug Dictionary galeterone
UNSPSC Code 51111800
NACRES NA.77

SAFETY

Risk and Safety Statements

Symbol(GHS)  Health Hazard (GHS08)
GHS08
Signal word  Danger
Hazard statements  H361
Precautionary statements  P201-P202-P281-P308+P313-P405-P501
WGK Germany  WGK 3
Storage Class 11 - Combustible Solids

Galeterone price More Price(59)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML1375 Galeterone ≥98% (HPLC) 851983-85-2 5MG $86 2026-04-30 Buy
Sigma-Aldrich SML1375 Galeterone ≥98% (HPLC) 851983-85-2 25MG $331 2026-04-30 Buy
Cayman Chemical 17586 Galeterone ≥98% 851983-85-2 1mg $28 2026-04-30 Buy
Cayman Chemical 17586 Galeterone ≥98% 851983-85-2 5mg $97 2026-04-30 Buy
Cayman Chemical 17586 Galeterone ≥98% 851983-85-2 10mg $152 2026-04-30 Buy
Product number Packaging Price Buy
SML1375 5MG $86 Buy
SML1375 25MG $331 Buy
17586 1mg $28 Buy
17586 5mg $97 Buy
17586 10mg $152 Buy

Galeterone Chemical Properties,Uses,Production

Description

Galeterone (TOK-001) is a small molecule oral drug that disrupts AR signaling by a novel triple mechanism: it potently and selectively inhibits CYP17 lyase, potently antagonizes AR and decreases AR protein levels (wild-type and mutant), leading to antitumor activity. Galeterone has shown significant anti-tumour activity with a well-tolerated safety profile in patients with CRPC in phase I and II clinical studies.

Uses

Galeterone is an androgen receptor antagonist and CYP17A1 enzyme inhibitor. It has been used in trials studying the treatment of Prostate Cancer.

Definition

ChEBI: Galeterone is a 3-hydroxy steroid. It has a role as an androgen.

Biological Activity

The cytochrome P450 (CYP) isoform CYP17 is also known as steroid 17α-hydroxylase/17,20 lyase because it catalyzes both 17α-hydroxylase and 17,20 lyase reactions in the synthesis of steroids, including androgens, estrogens, glucocorticoids, and mineralocorticoids. Galeterone is a CYP17 inhibitor (IC50 = 300 nM) that has been shown to competitively block synthetic androgen binding (EC50 = 845 nM) and to antagonize the androgen receptor in transcriptional activation assays. Galeterone can inhibit the growth of castration-resistant prostate cancer cells with an IC50 value of 2.9 μM and demonstrates synergy with everolimus or gefitinib for growth inhibition.

Synthesis

(3beta)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol 3-acetate

851895-79-9

Galeterone

851983-85-2

GENERAL STEPS: (3BETA)-17-(1H-benzimidazol-1-yl)androsta-5,16-dien-3-ol 3-acetate (1.3 g, 3.02 mmol) was dissolved in methanol (20 mL) under an inert argon (Ar) atmosphere. To the resulting solution was added 10% potassium methanol (KOH) solution (8 mL). The reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was subsequently concentrated under reduced pressure to a volume of about 10 mL at about 40 °C. The concentrated solution was poured into ice water (300 mL), and the precipitated white precipitate was filtered, washed with water and dried. The target product (3β-hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene) was obtained by solvent recrystallization over a mixture of ethyl acetate (EtOAc)/methanol (MeOH) (1.10 g, 94% yield), melting point 189-190 °C. Infrared spectra (CHCl3) showed absorption peaks located at 2934, 2339, 1609, 1490, 1453, 1291, 1040, 837, 808, 705, 663, 608, 578, 550, 517 cm-1 .1H NMR (300 MHz, CDCl3) δ 1.02 (s, 3H, 18-CH3) 1.07 (s, 3H, 19-CH3), 3.55 (m, 1H, 3α-H), 5.41 (br s, 1H, 6-H), 5.99 (s, 1H, 16-H), 7.30 (m, 2H, aromatic-H), 7.54 (s, 1H, aromatic-H), 7.80 (s, 1H, aromatic-H), 7.96 (s, 1H, 2X-H). . The calculated value of high resolution mass spectrometry (HRMS) was 411.2407 (C26H32ON2-Na+) and the measured value was 411.2396.

target

CYP17

storage

Store at -20°C

Mode of action

Galeterone is an orally bioavailable small-molecule androgen receptor modulator and CYP17 lyase inhibitor with potential antiandrogen activity. Galeterone exhibits three distinct mechanisms of action: 1) as an androgen receptor antagonist, 2) as a CYP17 lyase inhibitor and 3) by decreasing overall androgen receptor levels in prostate cancer tumors, all of which may result in a decrease in androgen-dependent growth signaling. Localized to the endoplasmic reticulum (ER), the cytochrome P450 enzyme CYP17 (P450C17 or CYP17A1) exhibits both 17alpha-hydroxylase and 17,20-lyase activities, and plays a key role in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens.

References

[1]. devore n m, & scott e e. structures of cytochrome p450 17a1 with prostate cancer drugs abiraterone and tok-001. nature, 2012, 482: 116-119.
[2]. mallik i, davila m, tapia t, et al. androgen regulates cdc6 transcription through interactions between androgen receptor and e2f transcription factor in prostate cancer cells. biochimica et biophysica acta (bba) - molecular cell research, 2008,1783:1737-1744.
[3]. bruno r d, vasaitis t s, gediya l. k, et al. synthesis and biological evaluations of putative metabolically stable analogs of vn/124-1 (tok-001): head to head anti-tumor efficacy evaluation of vn/124-1 (tok-001) and abiraterone in lapc-4 human prostate cancer xenograft model. steroids, 2011,76: 1268-1279.

Galeterone Preparation Products And Raw materials

Global( 157)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806 sales@capot.com China 29640 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 33024 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 965 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19936 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49979 58
career henan chemical co
+86-0371-86658258 +8613203830695 factory@coreychem.com China 29792 58
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354 marketing@targetmol.com United States 32467 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 28675 58
AFINE CHEMICALS LIMITED
+86-571-85134551 info@afinechem.com China 15083 58
Shenzhen Shengda Pharma Limited
755-85269922 +8613424394241 sales@shengdapharm.com CHINA 310 58

View Lastest Price from Galeterone manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Galeterone pictures 2026-06-16 Galeterone
851983-85-2
$200.00-3000.00 1g 98% 1kg Shenzhen Nexconn Pharmatechs Ltd
Galeterone pictures 2026-04-21 Galeterone
851983-85-2
$52.00-143.00 99.77% 10g TargetMol Chemicals Inc.
Galeterone pictures 2020-01-09 Galeterone
851983-85-2
$6.68 1KG 97%-99% 1kg-1000kg Career Henan Chemical Co
  • Galeterone pictures
  • Galeterone
    851983-85-2
  • $200.00-3000.00
  • 98%
  • Shenzhen Nexconn Pharmatechs Ltd
  • Galeterone pictures
  • Galeterone
    851983-85-2
  • $52.00-143.00
  • 99.77%
  • TargetMol Chemicals Inc.
  • Galeterone pictures
  • Galeterone
    851983-85-2
  • $6.68
  • 97%-99%
  • Career Henan Chemical Co

Galeterone Spectrum

(3β)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol CS-232 VN/124-1; GALETERONE;TOK001;TOK 001;TOK-001 Galaterone NX41765 (3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (3beta)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol Galeterone VN 124 TOK-001 (Galeterone) Galeterone,TOK-001 (3S,10R,13S)-17-(1H-benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol TOK-001 VN/124-1 Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3β)- GALETERONE;TOK001;TOK 001;TOK-001 TOK-001 impurity synthesis-008 synthesis-1-007 Galeterone USP/EP/BP TOK-001/Galeterone,VN/124-1 Androsta-?5,?16-?dien-?3-?ol, 17-?(1H-?benzimidazol-?1-?yl)?-?, (3β)?- Galeterone, TOK-001, VN-124-1 Galeterone, 10 mM in DMSO Galeterone Impurity1 851983-85-2 Inhibitors API